Insights

Global Clinical Trials Platform ICON plc operates from 81 locations across 38 countries, demonstrating a wide geographic reach that supports multinational clinical development projects. This extensive footprint presents opportunities to offer tailored solutions for regional regulatory compliance, local market engagement, and scalable trial management systems.

Innovative Service Launches Recent launches such as the Outcome Measures service line and the Centre for Obesity indicate ICON's focus on specialized, evidence-based approaches in clinical research. Partnering to provide complementary data analytics, patient recruitment, or market intelligence services could enhance their offerings and meet growing demand for precision medicine solutions.

Focus on Real-World Evidence The acquisition of Oxford Outcomes and emphasis on real-world evidence (RWE) research signals ICON's commitment to data-driven decision-making and outcome-based trials. Technologies and consulting services that enhance data collection, analysis, or regulatory submission processes in RWE could be valuable sales opportunities.

Technology Integration ICON employs advanced tech stacks including TensorFlow, Neo4j, and Boomi to streamline clinical operations and data management. Offering innovative AI, machine learning, or enterprise integration solutions can help ICON further optimize trial efficiency and accelerate drug development timelines.

Industry Challenges & Opportunities Despite recent legal challenges such as securities lawsuits, ICON continues to expand its service portfolio and strategic initiatives. Providing compliance, risk management, or legal consulting services alongside technological solutions could support the company's resilience and growth objectives in a competitive market.

ICON plc (formerly Averion International) Tech Stack

ICON plc (formerly Averion International) uses 8 technology products and services including WordPress, Oracle SOA Suite, Neo4j, and more. Explore ICON plc (formerly Averion International)'s tech stack below.

  • WordPress
    Content Management System
  • Oracle SOA Suite
    Data Management
  • Neo4j
    Database
  • Microsoft 365
    Email
  • TensorFlow
    Machine Learning
  • DocuSign
    Miscellaneous
  • Solaris
    Operating Systems & Computing Languages
  • Boomi
    Platform As A Service

Media & News

ICON plc (formerly Averion International)'s Email Address Formats

ICON plc (formerly Averion International) uses at least 2 format(s):
ICON plc (formerly Averion International) Email FormatsExamplePercentage
FLast@iconinternational.comJDoe@iconinternational.com
72%
First.Last@iconinternational.comJohn.Doe@iconinternational.com
18%
FirstL@iconinternational.comJohnD@iconinternational.com
2%
FirstLast@iconinternational.comJohnDoe@iconinternational.com
2%
FirLast@iconinternational.comJohDoe@iconinternational.com
1%
FMiddleLast@iconinternational.comJMichaelDoe@iconinternational.com
1%
First-Last@iconinternational.comJohn-Doe@iconinternational.com
1%
Last_First@iconinternational.comDoe_John@iconinternational.com
1%
Last.F@iconinternational.comDoe.J@iconinternational.com
1%
Fir.Last@iconinternational.comJoh.Doe@iconinternational.com
1%
First.Last@iconplc.comJohn.Doe@iconplc.com
93%
FirstLast@iconplc.comJohnDoe@iconplc.com
4%
First.L@iconplc.comJohn.D@iconplc.com
2%
Last.First@iconplc.comDoe.John@iconplc.com
1%

Frequently Asked Questions

What is ICON plc (formerly Averion International)'s stock symbol?

Minus sign iconPlus sign icon
ICON plc (formerly Averion International) is a publicly traded company; the company's stock symbol is CAV1V.HE.

What is ICON plc (formerly Averion International)'s official website and social media links?

Minus sign iconPlus sign icon
ICON plc (formerly Averion International)'s official website is iconplc.com and has social profiles on LinkedIn.

How much revenue does ICON plc (formerly Averion International) generate?

Minus sign iconPlus sign icon
As of February 2026, ICON plc (formerly Averion International)'s annual revenue is estimated to be $7.3M.

What is ICON plc (formerly Averion International)'s NAICS code?

Minus sign iconPlus sign icon
ICON plc (formerly Averion International)'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does ICON plc (formerly Averion International) have currently?

Minus sign iconPlus sign icon
As of February 2026, ICON plc (formerly Averion International) has approximately 56 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: H. B.Chief Executive Officer: M. R.Vice President Corporate Trade: B. A. D.. Explore ICON plc (formerly Averion International)'s employee directory with LeadIQ.

What industry does ICON plc (formerly Averion International) belong to?

Minus sign iconPlus sign icon
ICON plc (formerly Averion International) operates in the Pharmaceutical Manufacturing industry.

What technology does ICON plc (formerly Averion International) use?

Minus sign iconPlus sign icon
ICON plc (formerly Averion International)'s tech stack includes WordPressOracle SOA SuiteNeo4jMicrosoft 365TensorFlowDocuSignSolarisBoomi.

What is ICON plc (formerly Averion International)'s email format?

Minus sign iconPlus sign icon
ICON plc (formerly Averion International)'s email format typically follows the pattern of FLast@iconinternational.com. Find more ICON plc (formerly Averion International) email formats with LeadIQ.

When was ICON plc (formerly Averion International) founded?

Minus sign iconPlus sign icon
ICON plc (formerly Averion International) was founded in 1980.

ICON plc (formerly Averion International)

Pharmaceutical Manufacturing51-200 Employees

Averion International Corp. was acquired by Aptiv Solutions, which is now ICON plc. For the latest news and updates visit the ICON plc page. 

About ICON 

ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 81 locations in 38 countries and has approximately 11,200 employees. Further information is available at www.iconplc.com.

Section iconCompany Overview

Stock Symbol
CAV1V.HE
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1980
Employees
51-200

Section iconFunding & Financials

  • $250M$500M

    ICON plc (formerly Averion International)'s revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $250M$500M

    ICON plc (formerly Averion International)'s revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.